{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:02:03Z","timestamp":1792854123915,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.clineuro.2011.03.016","type":"journal-article","created":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T22:23:43Z","timestamp":1303424623000},"page":"559-563","source":"Crossref","is-referenced-by-count":41,"title":["The association of sporadic inclusion body myositis and Sj\u00f6gren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype"],"prefix":"10.1016","volume":"113","author":[{"given":"A.","family":"Rojana-udomsart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Needham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.B.","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Zilko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.L.","family":"Mastaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clineuro.2011.03.016_bib0005","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1750-3639.2009.00290.x","article-title":"Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation","volume":"19","author":"Askanas","year":"2009","journal-title":"Brain Pathol"},{"issue":"8","key":"10.1016\/j.clineuro.2011.03.016_bib0010","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/ncpneuro0261","article-title":"Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies","volume":"2","author":"Dalakas","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"issue":"2A","key":"10.1016\/j.clineuro.2011.03.016_bib0015","first-page":"261","article-title":"Primary Sjogren syndrome and inclusion body myositis","volume":"34","author":"Monteiro","year":"2009","journal-title":"Acta Reumatol Port"},{"issue":"4","key":"10.1016\/j.clineuro.2011.03.016_bib0020","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/rheumatology\/41.4.440","article-title":"Primary Sjogren's syndrome associated with inclusion body myositis","volume":"41","author":"Kanellopoulos","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.clineuro.2011.03.016_bib0025","first-page":"306","article-title":"Inclusion body myositis in association with vitamin B12 deficiency and Sjogren's syndrome","volume":"19","author":"Khraishi","year":"1992","journal-title":"J Rheumatol"},{"issue":"10","key":"10.1016\/j.clineuro.2011.03.016_bib0030","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/archneur.1985.04060090107026","article-title":"Inclusion body myositis and Sjogren's syndrome","volume":"42","author":"Gutmann","year":"1985","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.clineuro.2011.03.016_bib0035","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1001\/archneur.1982.00510150056014","article-title":"Inclusion body myositis associated with Sjogren's syndrome","volume":"39","author":"Chad","year":"1982","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.clineuro.2011.03.016_bib0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2249.1994.tb06604.x","article-title":"HLA associations with inclusion body myositis","volume":"98","author":"Garlepp","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"12","key":"10.1016\/j.clineuro.2011.03.016_bib0045","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1212\/01.WNL.0000148588.15052.4C","article-title":"Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis","volume":"63","author":"Badrising","year":"2004","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.clineuro.2011.03.016_bib0050","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00415-003-0204-3","article-title":"Analysis of HLA class I and II alleles in sporadic inclusion-body myositis","volume":"250","author":"Lampe","year":"2003","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.clineuro.2011.03.016_bib0055","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-4598(199801)21:1<115::AID-MUS15>3.0.CO;2-2","article-title":"Immune-mediated conditions and antibodies associated with sporadic inclusion body myositis","volume":"21","author":"Koffman","year":"1998","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.clineuro.2011.03.016_bib0060","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.nmd.2009.07.015","article-title":"Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype","volume":"19","author":"Mastaglia","year":"2009","journal-title":"Neuromuscul Disord"},{"issue":"5","key":"10.1016\/j.clineuro.2011.03.016_bib0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.nmd.2006.02.002","article-title":"Sporadic inclusion body myositis in Japanese is associated with the MHC ancestral haplotype 52.1","volume":"16","author":"Scott","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.clineuro.2011.03.016_bib0070","series-title":"The 8th Congress of World Muscle Society","article-title":"Central MHC genes on two haplotypes affect inclusion body myositis","author":"Santoso","year":"2003"},{"issue":"7","key":"10.1016\/j.clineuro.2011.03.016_bib0075","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0198-8859(01)00253-1","article-title":"HLA class I and class II are both associated with the genetic predisposition to primary Sjogren syndrome","volume":"62","author":"Loiseau","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/j.clineuro.2011.03.016_bib0080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-065X.1999.tb01398.x","article-title":"The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases","volume":"167","author":"Price","year":"1999","journal-title":"Immunol Rev"},{"issue":"6","key":"10.1016\/j.clineuro.2011.03.016_bib0085","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.clineuro.2011.03.016_bib0090","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/ana.410380504","article-title":"Inclusion body myositis and myopathies","volume":"38","author":"Griggs","year":"1995","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.clineuro.2011.03.016_bib0095","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1186\/ar2669","article-title":"Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases","volume":"11","author":"Gabriel","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.clineuro.2011.03.016_bib0100","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ncprheum0173","article-title":"Mechanisms of disease: primary Sjogren's syndrome and the type I interferon system","volume":"2","author":"Nordmark","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"21","key":"10.1016\/j.clineuro.2011.03.016_bib0105","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1212\/01.WNL.0000291619.17160.b8","article-title":"Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications","volume":"69","author":"Greenberg","year":"2007","journal-title":"Neurology"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846711000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846711000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T02:57:37Z","timestamp":1543805857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846711000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0303846711000874"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2011.03.016","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}